In addition, many drugs that can be used to treat Alzheimer’s disease by activating NRF2, such as resveratrol, pyridoxine, and NBP (n-butylphthalide), have also entered clinical trials. The gene discussed is NFE2L2; the disease is Alzheimer disease.